Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guanghui Tian

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
ACS Infectious Diseases|April 27, 2026
Rational Design and Screening of Chemically Modified Anti-SARS-CoV-2 siRNAZihui Cheng, Ying Cai, Enhua Zhang, et al.
Cancer Science|September 3, 2025
Integrative Transcriptomic Analysis Decodes the Interplay Between Aging, Senescence, and CancerJiale Cai, Deng Wu, Dahua Xu, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2018
Synthesis and biological evaluation of a series of novel pyridinecarboxamides as potential multi-receptor antipsychotic drugsMingshuo Xu, Yu Wang, Feipu Yang, et al.
European Journal of Medicinal Chemistry|November 6, 2024
Discovery of peptidomimetic spiropyrrolidine derivatives as novel 3CL<sup>pro</sup> inhibitors against SARS-CoV -2Samuel Desta Guma, Zhaoyin Zhou, Kang Song, et al.
Archiv Der Pharmazie|February 1, 2019
Continuation of structure-activity relationship study of novel benzamide derivatives as potential antipsychoticsMingshuo Xu, Shuang Guo, Feipu Yang, et al.
European Journal of Medicinal Chemistry|January 12, 2018
Synthesis and biological evaluation of a series of multi-target N-substituted cyclic imide derivatives with potential antipsychotic effectMingshuo Xu, Yu Wang, Feipu Yang, et al.
Drug Design, Development and Therapy|July 15, 2021
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy SubjectsHongjie Qian, Qian Chen, Liyu Liang, et al.
Journal of Medicinal Chemistry|June 20, 2025
Identification of Cannabigerol-Derived Dual CB<sub>2</sub> Receptor Agonists and TRPM8 Antagonists with Anti-Inflammatory and Analgesic ActivitiesWenjiao Yang, Haiguo Sun, Jing Ji, et al.
Journal of Medicinal Chemistry|July 1, 2011
Utilization of halogen bond in lead optimization: a case study of rational design of potent phosphodiesterase type 5 (PDE5) inhibitorsZhijian Xu, Zheng Liu, Tong Chen, et al.
Computers in Biology and Medicine|December 6, 2023
Mapping enhancer and chromatin accessibility landscapes charts the regulatory network of Alzheimer's diseaseDahua Xu, Chunrui Zhang, Xiaoman Bi, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
ACS Infectious Diseases|April 27, 2026
Rational Design and Screening of Chemically Modified Anti-SARS-CoV-2 siRNAZihui Cheng, Ying Cai, Enhua Zhang, et al.
Cancer Science|September 3, 2025
Integrative Transcriptomic Analysis Decodes the Interplay Between Aging, Senescence, and CancerJiale Cai, Deng Wu, Dahua Xu, et al.
Bioorganic & Medicinal Chemistry Letters|February 4, 2018
Synthesis and biological evaluation of a series of novel pyridinecarboxamides as potential multi-receptor antipsychotic drugsMingshuo Xu, Yu Wang, Feipu Yang, et al.
European Journal of Medicinal Chemistry|November 6, 2024
Discovery of peptidomimetic spiropyrrolidine derivatives as novel 3CL<sup>pro</sup> inhibitors against SARS-CoV -2Samuel Desta Guma, Zhaoyin Zhou, Kang Song, et al.
Archiv Der Pharmazie|February 1, 2019
Continuation of structure-activity relationship study of novel benzamide derivatives as potential antipsychoticsMingshuo Xu, Shuang Guo, Feipu Yang, et al.
European Journal of Medicinal Chemistry|January 12, 2018
Synthesis and biological evaluation of a series of multi-target N-substituted cyclic imide derivatives with potential antipsychotic effectMingshuo Xu, Yu Wang, Feipu Yang, et al.
Drug Design, Development and Therapy|July 15, 2021
A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TPN171H, a Novel Phosphodiesterase Type 5 Inhibitor, in Healthy SubjectsHongjie Qian, Qian Chen, Liyu Liang, et al.
Journal of Medicinal Chemistry|June 20, 2025
Identification of Cannabigerol-Derived Dual CB<sub>2</sub> Receptor Agonists and TRPM8 Antagonists with Anti-Inflammatory and Analgesic ActivitiesWenjiao Yang, Haiguo Sun, Jing Ji, et al.
Journal of Medicinal Chemistry|July 1, 2011
Utilization of halogen bond in lead optimization: a case study of rational design of potent phosphodiesterase type 5 (PDE5) inhibitorsZhijian Xu, Zheng Liu, Tong Chen, et al.
Computers in Biology and Medicine|December 6, 2023
Mapping enhancer and chromatin accessibility landscapes charts the regulatory network of Alzheimer's diseaseDahua Xu, Chunrui Zhang, Xiaoman Bi, et al.
Pageof 6